US Patent Issued to PPM BIOPHARMA on Feb. 4 for "Pleiotropic pathway modifier compounds and method of treating diseases" (New Jersey Inventors)

ALEXANDRIA, Va., Feb. 5 -- United States Patent no. 12,215,092, issued on Feb. 4, was assigned to PPM BIOPHARMA LLC (Berkeley Heights, N.J.).

"Pleiotropic pathway modifier compounds and method of treating diseases" was invented by Mingwen Wang (Berkeley Heights, N.J.) and Linghua Zhang (Berkeley Heights, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This patent document reveals a class of pleiotropic pathway modifier (known as PPM) compounds that facilitate the degradation of multiple targeted proteins and regulate various signaling events involved in cancer cell survival and proliferation, as well as immune response. These compounds effectively recruit disease-causing proteins for swift destruction th...